Sage Journals: Discover world-class research

Retricted access

Research article

First published 2024

Real world comparison of immune-related adverse events with nivolumab-relatlimab versus ipilimumab-nivolumab in patients with advanced cutaneous melanoma

Brooke Kielkowski, Diana Mansour, Brooke Ebbert [...]

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2021-4

Comparative effectiveness of second-line ipilimumab vs. nivolumab in combination with ipilimumab in patients with advanced melanoma who received frontline anti-PD-1 antibodies

Kelsey Baron, Justin C Moser, Shiven Patel [...]

Journal of Oncology Pharmacy Practice

Retricted access

Case report

First published 2023-7

Widespread vitiligo and poliosis following ipilimumab–nivolumab combination therapy

Khashayar Nemovi, Arsia Jamali, Keyan Matinpour [...]

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2023-4

A comprehensive evaluation of the safety of ipilimumab,nivolumab and their combination therapy: A systematic review and network meta-analysis

Mahanjit Konwar, Debdipta Bose, Miteshkumar Maurya [...]

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2026

Effectiveness and safety of first-line nivolumab–ipilimumab in metastatic renal cell carcinoma

Miguel Escario Gómez, Macarena García-Trevijano Cabetas, Clara Herranz Muñoz [...]

Journal of Oncology Pharmacy Practice

Open access

Case report

First published 2021

Acute motor axonal neuropathy after ipilimumab and nivolumab treatment in melanoma brain metastases: A case report and review of the literature

Yolanda Piña, Brittany R. Evernden, Nikhil Khushalani [...]

Sage Open Medical Case Reports

Retricted access

Review article

First published 2015-8

Current Status and Future Directions of the Immune Checkpoint Inhibitors Ipilimumab,Pembrolizumab,and Nivolumab in Oncology

Meagan S. Barbee, Adebayo Ogunniyi, Troy Z. Horvat [...]

Annals of Pharmacotherapy

Open access

Case report

First published 2023

Lichenoid drug reaction after ipilimumab/nivolumab combination therapy: A case report

Zonía Robenne Moore, Dalit Zajdman-Faitelson, Arely Tamariz Campillo [...]

Sage Open Medical Case Reports

Open access

Case report

First published 2021

Hyponatremia and Fever in a Patient on Ipilimumab and Nivolumab (Immune Checkpoint Inhibitors): A Case Report

Sumit S. Patel, Sasmit Roy, Mytri Pokal [...]

Journal of Investigative Medicine High Impact Case Reports

Open access

Research article

First published 2023-12-18

Genomic and Transcriptomic Characteristics of Tumors of Patients with Metastatic Clear Cell Renal Cell Carcinoma Clinically Benefiting from First-Line Treatment with Ipilimumab Plus Nivolumab

Nishita Tripathi, Luis Meza, Nicolas Sayegh [...]

Kidney Cancer

Search results